A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.

Abroad (travel likely)RecruitingPHASE2

Conditions

Melanoma (Skin Cancer)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UZ Brussel, Jette, Brussels Capital, Belgium
Contact: Study coordinator (Prof. Dr. Bart Neyns) · bart.neyns@uzbrussel.be · +32 2 477 60 40

Study leads

Bart Neyns, Prof, MD, PhD
Principal Investigator
Universitair Ziekenhuis Brussel

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Advanced Malignancies · Ovarian Cancer · T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States · New York, United States

A Beta-only IL-2 ImmunoTherapY Study

Advanced Solid Tumor · Unresectable Solid Tumor · Clear Cell Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Diego, United States · San Francisco, United States

Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease

Non Small Cell Lung Cancer · Head and Neck Squamous Cell Carcinoma · Melanoma

Abroad (travel likely)RecruitingPHASE2

Darmstadt, Germany · Milan, Italy

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

Pancreatic Cancer · Renal Cell Cancer · Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States